Navigation Links
Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay.
Date:8/25/2014

es sensitivity of detecting high-risk HPV in patients with CIN2/3 in urine versus cervical samples is ongoing and results will be reported by Q1 2015."About Trovagene, Inc.

Headquartered in San Diego, California, Trovagene is leveraging its patented technology for the detection of cell-free DNA, short nucleic acid fragments originating from normal and diseased cell death that can be isolated and detected from urine. Trovagene has a strong intellectual property asset as it relates to cell-free DNA testing in urine. It has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; clinical trials involve a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results; uncertainties of government or fourth party payer reimbursement; limited sales and marketing efforts and dependence upon fourth parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in th
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial
2. ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees
3. KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema
4. Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting
5. DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer
6. Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
7. Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
8. Major Clinical Study Supports NIPT As First Line Screening Test For All Pregnant Women
9. VolitionRx Invests in Laboratory Automation System to Increase Throughput Capacity for Large Clinical Trials
10. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
11. BioSpecifics Technologies Corp. Announces Initiation of Phase 2 Clinical Study of CCH for Treatment of Lipoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
(Date:8/31/2015)... , Aug. 31, 2015  DICOM Grid,  ... today that it was recognized as a semifinalist ... software.  The awards are sponsored by ... related professionals in the medical imaging industry.  Since ... radiology professionals to acknowledge the contributions of their ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... Tenn. , May 20 /PRNewswire-FirstCall / -- Cumberland Pharmaceuticals Inc. ... acute care and gastroenterology markets, today announced that Chief Commercial Officer ... Global Life Sciences Conference in New York at 11:30 ... , , , ...
... , May 20 LightLab Imaging, Inc. announced today that ... leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University ... available to hospitals in the United States – Optical Coherence ... Dr. Costa ...
Cached Medicine Technology:Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 3
(Date:8/31/2015)... ... , ... According to an article published August 3rd on Healio, ... underwent bariatric surgery “felt significantly better two years after surgery.” The article goes on ... study felt that their “mental health had been normalized” at the point when the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, son Scott, ... on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, but the ... Call Center and website since Aug. 17. , The Greens have operated Green ...
(Date:8/31/2015)... Knoxville, TN (PRWEB) , ... August 31, 2015 ... ... of urgent care and accessible primary care, is enhancing its existing presence in ... Pike in Knoxville. The location is the company’s second in Knoxville, sixteenth in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a leader ... competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the company’s ... Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking place ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... In ... studies, Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 ... sound amplifiers as a way of coping with a variety of home healthcare challenges, ...
Breaking Medicine News(10 mins):Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... YORK (Aug. 21, 2007) -- A breakthrough new ... and adults with a common type of congenital ... to oxygenate blood through the lungs. , The ... the first-ever catheter-based pulmonary valve replacement, is currently ...
... researchers say , WEDNESDAY, Aug. 22 (HealthDay News) -- ... humans with obsessive-compulsive disorder (OCD), scientists report. , The ... cells from producing a protein called SAPAP3, according to ... an important role in the transmission of signals between ...
... a dark side, but also a new way it ... -- It looks like HDL, the "good" cholesterol that ... side. , New research suggests that some people,s HDL ... that certain proteins in HDL can exacerbate vessel damage, ...
... scientists reported findings today demonstrating the presence of Marburg ... of African fruit bat (Rousettus aegyptiacus). , ... study is the first in which RT-PCR and serological ... bat species. The natural reservoir for Marburg virus has ...
... of secondary procedures , , TUESDAY, Aug. 21 (HealthDay News) ... peritonitis may not automatically need to undergo more operations ... In the United States, most surgeons choose to wait ... surgery, said Dr. David Flum, a gastrointestinal surgeon at ...
... highly effective in preventing the behavioral and academic problems ... a five-year study led by researchers at Lehigh Universitys ... and funded by the National Institute of Mental Health ... children aged 3 to 5 who have shown significant ...
Cached Medicine News:Health News:NYC-area 1st: Morgan Stanley Children's Hospital performs transcatheter pulmonary valve replacement 2Health News:When 'Good' Cholesterol Goes Bad 2Health News:Scientists detect presence of marburg virus in african fruit bats 2Health News:One Surgery Often Enough for Peritonitis 2Health News:Nonmedicinal treatment touted for preschoolers with ADHD 2Health News:Nonmedicinal treatment touted for preschoolers with ADHD 3
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... X-Drape combines full 0.25 mm pb ... sterile drape material that can be ... between the clinician and the source ... clinician must be in very close ...
... The first mobile clinical assistant ... A convergence of technologies in the ... you normally do during your,shift such ... and take pictures using one single ...
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Medicine Products: